R2202115 |
PFI-90 |
PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX
|
R2202116 |
TBAP-001 |
TBAP-001 (Synthesis 13), extracted from patent WO2015075483A1, is a pan-RAF kina
|
R2202117 |
Robinetin |
Robinetin (3,3',4',5',7-Pentahydroxyflavone), a naturally occurring flavonoid wi
|
R2202118 |
MRTX1133 |
MRTX1133 is a noncovalent, potent, and selective KRAS G12D inhibitor. MRTX1133 o
|
R2202119 |
HLY78 |
HLY78 is an activator of the Wnt/β-catenin signaling pathway, which targets the
|
R2202120 |
SB-265610 |
SB-265610 is a selective, competitive, nonpeptide and allosteric CXCR2 antagonis
|
R2202121 |
GSK2033 |
GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectiv
|
R2202122 |
KL-11743 |
KL-11743 is a potent, orally active, and glucose-competitive inhibitor of the cl
|
R2202123 |
Ch55 |
Ch55 is a potent synthetic retinoid. Ch55 binds to RAR-α and RAR-β receptors wit
|
R2103226 |
Polyphyllin I |
Polyphyllin I is a bioactive constituent extracted from Paris polyphylla, h
|
R2001291 |
Coti-2 |
COTI-2, an anti-cancer drug with low toxicity, is an orally available third gene
|
R2204121 |
Lisavanbulin |
(S)-2,6-diamino-N-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1H-ben
|
R2204201 |
MRTX-1719 |
MRTX-1719 is a potent first-in-class selective inhibitor of the PRMT5/MTA&n
|
R2202125 |
Remibrutinib(LOU064) |
Remibrutinib, is a potent and orally active bruton tyrosine kinase (BTK) inhibit
|
R2202126 |
AZD9056 hydrochloride |
AZD9056 hydrochloride is a selective orally active inhibitor of P2X7 which plays
|
R2202127 |
UCB-9260 |
UCB-9260, an orally active compound, inhibits TNF signaling by stabilising an as
|
R2202128 |
LM22A-4 |
LM22A-4 is a specific agonist of tyrosine kinase receptor B, used for neurologic
|
R2202129 |
BI-4464 |
BI-4464 is a highly selective ATP competitive inhibitor of PTK2/FAK, with an IC5
|
R2204281 |
Brusatol |
Brusatol (NSC 172924) is a unique inhibitor of the Nrf2 pathway t
|
R2202132 |
Besifovir (LB8033) |
Besifovir (LB80331), a parent drug converted by LB80380, further metabolizes to
|
R2202133 |
Cichoric Acid |
Cichoric Acid, a natural product, is reported to be antioxidative.
|
R2202134 |
BMS-P5 hydrochloride |
BMS-P5 is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhib
|
R2202135 |
Letrozole |
Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-s
|
R2202136 |
Anastrozole |
Anastrozole is a potent, highly selective aromatase inhibitor, which inhibits hu
|
R2202137 |
Glibenclamide impurity Ⅱ |
Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) in
|